Effect of Alveolar Ridge Preservation on Implant Esthetic Outcomes

University of Belgrade

Status and phase: Completed; Phase 4

Conditions: Partial Edentulism

Treatments: Drug: no-preservation of alveolar ridge - 9 months; Drug: no-preservation of alveolar ridge - 4 months; Drug: preservation of alveolar ridge with beta tricalcium phosphate + collagen - 4 months; Drug: no-preservation of alveolar ridge - 2 months; Drug: preservation of alveolar ridge with beta tricalcium phosphate + collagen - 2 months; Procedure: preservation of alveolar ridge with beta tricalcium phosphate + collagen - 9 months

Study type: Interventional

Funder types: Other

Identifiers

NCT02507661

36/21

Details and patient eligibility

About

The purpose of this study is to evaluate esthetic outcome of implant supported single crowns after alveolar ridge preservation with beta three calcium phosphate with collagen type I in aesthetic region in upper jaw.

Enrollment: 50 patients

Sex: All

Ages: 18 to 35 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• healthy patients according to Classification of American Society of Anesthesiologists (ASA I)
• presence of 4 socket walls
• non-smokers
• good oral hygiene
• good occlusion

Exclusion criteria

• patients with alveolar ridge height less than 12 mm
• presence of acute or chronic oro-facial pain
• acute periapical infection
• injured soft tissue
• patients who had dental interventions in last 7 days
• patients who had any medications within last 24 hours
• patients with bruxism and para-functions
• patients with allergies to any of applied materials

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

50 participants in 6 patient groups

alveolar ridge preservation - 2 months

Experimental group

Description:

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 2 months

Treatment:

Drug: preservation of alveolar ridge with beta tricalcium phosphate + collagen - 2 months

no-preservation of alveolar ridge - 2 months

Active Comparator group

Description:

no-preservation of alveolar ridge - 2 months

Treatment:

Drug: no-preservation of alveolar ridge - 2 months

preservation of alveolar ridge - 4 months

Experimental group

Description:

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 4 months

Treatment:

Drug: preservation of alveolar ridge with beta tricalcium phosphate + collagen - 4 months

no-preservation of alveolar ridge - 4 months

Active Comparator group

Description:

no-preservation of alveolar ridge - 4 months

Treatment:

Drug: no-preservation of alveolar ridge - 4 months

preservation of alveolar ridge - 9 months

Experimental group

Description:

preservation of alveolar ridge with beta tricalcium phosphate + collagen - 9 months

Treatment:

Procedure: preservation of alveolar ridge with beta tricalcium phosphate + collagen - 9 months

no-preservation of alveolar ridge - 9 months

Active Comparator group

Description:

no-preservation of alveolar ridge - 9 months

Treatment:

Drug: no-preservation of alveolar ridge - 9 months